NCT00376688 2020-02-24Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast CancerNational Cancer Institute (NCI)Phase 2 Completed31 enrolled 5 charts
NCT00062751 2011-04-15Study Evaluating Temsirolimus (CCI-779) In Breast NeoplasmsWyeth is now a wholly owned subsidiary of PfizerPhase 2 Completed108 enrolled 4 charts